ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Panel Explores Barriers In Access To Cancer Care.

February 2, 2001

In Brief: Robert Young Named President Of Fox Chase; Elion, Hitchings Share Nobel Prize With Birton

October 21, 1988

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says.

November 3, 2000